This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Sevoflurane, Propofol, Postoperative Pain

This study has been completed.
Information provided by (Responsible Party):
Arvi Yli-Hankala, Tampere University Hospital Identifier:
First received: September 19, 2011
Last updated: April 9, 2013
Last verified: April 2013
The impact of anaesthetic method (intravenous vs. inhalational) has been proposed, but not proven in a large-scale study. The researchers aim to provide an investigation that has sufficient power to clarify the potential effect of anaesthetic method on postoperative need of opioids. Sevoflurane and propofol will be compared.

Condition Intervention Phase
Healthy Adults Gynecological Disease Drug: Sevoflurane Drug: Propofol Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Postoperative Pain After Propofol Sevoflurane Anaesthesia: a Prospective, Randomized, Single-blinded Trial

Resource links provided by NLM:

Further study details as provided by Arvi Yli-Hankala, Tampere University Hospital:

Primary Outcome Measures:
  • Postoperative consumption of an opioid (oxycodone) [ Time Frame: 20 hours ]
    The consumption of oxycodone will be monitored by recording the amount of the drug received via a commercially available patient controlled analgesia (PCA) pump.

Secondary Outcome Measures:
  • NRS (numeral rating scale) of pain [ Time Frame: 20 hours ]
    NRS is evaluated frequently during the study period.

Enrollment: 168
Study Start Date: October 2008
Study Completion Date: March 2013
Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Sevoflurane
    Sevoflurane inhalation anesthesia, sufficient amount to maintain adequate general anesthesia for surgery
    Other Name: Baxter Sevofluran
    Drug: Propofol
    Propofol intravenous anesthesia, sufficient amount to maintain adequate anesthesia during surgery
    Other Name: Propofol Lipuro

Ages Eligible for Study:   18 Years to 69 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age 18-69 years
  • Gender: female
  • ASA status 1-3
  • Laparoscopic hysterectomy

Exclusion Criteria:

  • Body Mass Index over 35
  • Diabetes mellitus
  • Liver disease
  • Allergies to pharmaceuticals used in the Study
  • Present use of opioids
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01437462

Tampere University Hospital
Tampere, Finland, 33521
Sponsors and Collaborators
Tampere University Hospital
  More Information

Responsible Party: Arvi Yli-Hankala, Professor, Tampere University Hospital Identifier: NCT01437462     History of Changes
Other Study ID Numbers: Satu_Pokkinen_01_2011
Study First Received: September 19, 2011
Last Updated: April 9, 2013

Keywords provided by Arvi Yli-Hankala, Tampere University Hospital:
Pain, Postoperative
Anesthetics, intravenous
Anesthetics, inhalation
Otherwise healthy adults undergoing general anesthesia for gynecological disease.

Additional relevant MeSH terms:
Pain, Postoperative
Genital Diseases, Female
Neurologic Manifestations
Nervous System Diseases
Postoperative Complications
Pathologic Processes
Signs and Symptoms
Central Nervous System Depressants
Physiological Effects of Drugs
Hypnotics and Sedatives
Anesthetics, Intravenous
Anesthetics, General
Platelet Aggregation Inhibitors
Anesthetics, Inhalation processed this record on September 21, 2017